ResMed Inc. logo
RMDResMed Inc.

Free Cash Flow (FCF): $1.75B

The free cash flow (FCF) is $1.75B. It is above its 12-month average by 3.25% ($1.69B).

Free Cash Flow

RMD Free Cash Flow (FCF)

$520.48M

Reported quarterly free cash flow; no daily interpolation.

+166.02% 5Y

RMD Quarterly Free Cash Flow Growth (YoY)

Free Cash Flow growth vs the same quarter one year earlier, last 20 quarters.

RMD Free Cash Flow (FCF)

RMD Average Free Cash Flow (FCF) Chart

RMD Free Cash Flow (FCF)

RMD Current vs Average Free Cash Flow (FCF) Chart

RMD Free Cash Flow (FCF) Metrics

FREE CASH FLOW (FCF)

$1.75B

FREE CASH FLOW (FCF) AVG TTM

$1.69B

FREE CASH FLOW (FCF) AVG 3Y

$1.24B

FREE CASH FLOW (FCF) AVG 5Y

$952.68M

FREE CASH FLOW (FCF) AVG 10Y

$548.13M

FREE CASH FLOW (FCF) AVG 15Y

$401.08M

FREE CASH FLOW (FCF) AVG 20Y

$308.52M

CURRENT VS TTM AVG

+3.25%

CURRENT VS 3Y AVG

+40.65%

CURRENT VS 5Y AVG

+83.50%

CURRENT VS 10Y AVG

+218.94%

CURRENT VS 15Y AVG

+335.87%

CURRENT VS 20Y AVG

+466.64%

FCF Analysis

Free Cash Flow (TTM)

$1.75B

FCF Yield

5.99%

Price/FCF

16.7

Formula: FCF = Operating Cash Flow - Capital Expenditures

Why FCF matters:

  • Shows actual cash available (not accounting earnings)
  • Funds dividends, buybacks, and debt reduction
  • Less susceptible to accounting manipulation than net income
  • Key metric for DCF valuation models

Free Cash Flow (FCF) Formula & Definition

Free Cash Flow represents the cash a company generates after accounting for capital expenditures. It's the cash available for dividends, buybacks, debt reduction, or reinvestment.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Free Cash Flow (FCF) FAQ

What is the free cash flow (FCF) for ResMed Inc. (RMD)?
The free cash flow (FCF) for RMD stock is $1.75B.
What is the TTM average free cash flow (FCF) for ResMed Inc. (RMD)?
The TTM average free cash flow (FCF) for RMD stock is $1.69B.
What is the 3Y average free cash flow (FCF) for ResMed Inc. (RMD)?
The 3Y average free cash flow (FCF) for RMD stock is $1.24B.
What is the 5Y average free cash flow (FCF) for ResMed Inc. (RMD)?
The 5Y average free cash flow (FCF) for RMD stock is $952.68M.
What is the 10Y average free cash flow (FCF) for ResMed Inc. (RMD)?
The 10Y average free cash flow (FCF) for RMD stock is $548.13M.
What is the 15Y average free cash flow (FCF) for ResMed Inc. (RMD)?
The 15Y average free cash flow (FCF) for RMD stock is $401.08M.
What is the 20Y average free cash flow (FCF) for ResMed Inc. (RMD)?
The 20Y average free cash flow (FCF) for RMD stock is $308.52M.

RMD Free Cash Flow (FCF) History

DATEFREE CASH FLOW (FCF)
2026-03-31$1.75B
2025-09-30$1.77B
2025-03-31$1.56B
2024-09-30$1.35B
2024-03-31$1.07B
2023-09-30$792.43M
2023-03-31$407.69M
2022-09-30$304.85M
2022-03-31$343.67M
2021-09-30$397.18M
2021-03-31$733.32M
2020-09-30$683.96M
2020-03-31$504.78M
2019-09-30$486.82M
2019-03-31$373.83M
2018-09-30$390.37M
2018-03-31$443.58M
2017-09-30$349.08M
2017-03-31$362.37M
2016-09-30$446.07M
2016-03-31$425.77M
2015-09-30$350.99M
2015-03-31$320.43M
2014-09-30$301.61M
2014-03-31$321.35M
2013-09-30$339.65M
2013-03-31$308.92M
2012-09-30$317.48M
2012-03-31$292.10M
2011-09-30$233.81M
2011-03-31$196.04M
2010-09-30$120.18M
2010-03-31$125.10M
2009-09-30$139.95M
2009-03-31$128.66M
2008-09-30$85.74M
2008-03-31$30.57M
2007-09-30$25.32M
2007-03-31$12.87M
2006-09-30$17.90M
2006-03-31$-7.67M
2005-09-30$-1.41M
2005-03-31$35.73M
2004-09-30$26.92M
2004-03-31$20.25M
2003-09-30$31.94M
2003-03-31$16.70M

About ResMed Inc.

ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.

San Diego, CA
9,980 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Michael J. Farrell